Switch to Moderna booster after Pfizer shots better against omicron in 60+

Ars Technica 2022-05-13

Summary:

The study is small but adds to data finding benefits of mix-and-match boosting.

Link:

https://arstechnica.com/?p=1854282

From feeds:

Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method
Cyberlaw » Ars Technica
Music and Digital Media » Ars Technica

Tags:

60

Authors:

Beth Mole

Date tagged:

05/13/2022, 18:15

Date published:

05/13/2022, 17:55